Literature DB >> 11746354

Transforming growth factor-beta1 enhances expression of brain-derived neurotrophic factor and its receptor, TrkB, in neurons cultured from rat cerebral cortex.

A Sometani1, H Kataoka, A Nitta, H Fukumitsu, H Nomoto, S Furukawa.   

Abstract

The effects of transforming growth factor (TGF)-beta1 on expression of brain-derived neurotrophic factor (BDNF) and its high-affinity receptor, TrkB, in neurons cultured from the cerebral cortex of 18-day-old embryonic rats were examined. BDNF mRNA was significantly increased from 24-48 hr after the TGF-beta1 treatment over 20 ng/ml. Accumulation of BDNF protein in the culture medium was also potentiated by TGF-beta1, although the intracellular content of BDNF was nearly unchanged. The enhancement of BDNF mRNA expression was suppressed by the co-presence of decorin, a small TGF-beta-binding proteoglycan that inhibits the biological activities of TGF-betas. mRNA expression of full-length TrkB, the bioactive high-affinity receptor for BDNF, was also upregulated after treatment with TGF-beta1. These observations suggest that: 1) TGF-beta1 potentiates BDNF/TrkB autocrine or local paracrine system; and 2) the neurotrophic activity of TGF-beta1 is partly responsible for the BDNF induced by TGF-beta1 itself. To test this latter possibility, we examined the neuronal survival activity of TGF-beta1 with or without K252a, a selective inhibitor of Trk family tyrosine kinases. TGF-beta1 significantly enhanced neuronal survival, but the co-presence of K252a completely suppressed the activity, demonstrating the involvement of Trk receptor signaling in TGF-beta1-mediated neuronal survival in cultured rat cortical neurons. These results seem to be in line with recent findings by other investigators that some neurotrophic factors including BDNF require TGF-betas as a cofactor to exert their neurotrophic activities. Copyright 2001 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11746354     DOI: 10.1002/jnr.1229

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  21 in total

Review 1.  The role of TGF-β superfamily signaling in neurological disorders.

Authors:  Risa Kashima; Akiko Hata
Journal:  Acta Biochim Biophys Sin (Shanghai)       Date:  2018-01-01       Impact factor: 3.848

Review 2.  TGF-β Family Signaling in Neural and Neuronal Differentiation, Development, and Function.

Authors:  Emily A Meyers; John A Kessler
Journal:  Cold Spring Harb Perspect Biol       Date:  2017-08-01       Impact factor: 10.005

Review 3.  Extracellular matrix abnormalities in schizophrenia.

Authors:  Sabina Berretta
Journal:  Neuropharmacology       Date:  2011-08-16       Impact factor: 5.250

4.  TGF-beta signaling specifies axons during brain development.

Authors:  Jason J Yi; Anthony P Barnes; Randal Hand; Franck Polleux; Michael D Ehlers
Journal:  Cell       Date:  2010-07-09       Impact factor: 41.582

5.  Central nervous system cytokine gene expression: modulation by lead.

Authors:  Jane Kasten-Jolly; Yong Heo; David A Lawrence
Journal:  J Biochem Mol Toxicol       Date:  2011 Jan-Feb       Impact factor: 3.642

6.  TSPYL2 is an essential component of the REST/NRSF transcriptional complex for TGFβ signaling activation.

Authors:  M T Epping; A Lunardi; D Nachmani; M Castillo-Martin; T H Thin; C Cordon-Cardo; P P Pandolfi
Journal:  Cell Death Differ       Date:  2015-01-23       Impact factor: 15.828

7.  Circulating TGF-beta1 does not cross the intact blood-brain barrier.

Authors:  Abba J Kastin; Victoria Akerstrom; Weihong Pan
Journal:  J Mol Neurosci       Date:  2003       Impact factor: 3.444

Review 8.  TGF-β1 pathway as a new target for neuroprotection in Alzheimer's disease.

Authors:  Filippo Caraci; Giuseppe Battaglia; Valeria Bruno; Paolo Bosco; Viviana Carbonaro; Maria Laura Giuffrida; Filippo Drago; Maria Angela Sortino; Ferdinando Nicoletti; Agata Copani
Journal:  CNS Neurosci Ther       Date:  2009-11-19       Impact factor: 5.243

9.  Neurotrophins role in depression neurobiology: a review of basic and clinical evidence.

Authors:  Fani L Neto; Gisela Borges; Sonia Torres-Sanchez; Juan A Mico; Esther Berrocoso
Journal:  Curr Neuropharmacol       Date:  2011-12       Impact factor: 7.363

10.  Intranasal delivery of transforming growth factor-beta1 in mice after stroke reduces infarct volume and increases neurogenesis in the subventricular zone.

Authors:  Minmin Ma; Yuping Ma; Xueming Yi; Ruibing Guo; Wusheng Zhu; Xinying Fan; Gelin Xu; William H Frey; Xinfeng Liu
Journal:  BMC Neurosci       Date:  2008-12-10       Impact factor: 3.288

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.